DCA results from the conversion of cholic acids to DCA via 7α-dehydroxylation and promotes metastases of BC tumors that have been grafted into the mouse fat pad by elevating Flk-1, a receptor for vascular endothelial growth factor, and decreasing ceramide-mediated apoptosis of BC cells (44). The gene discussed is VEGFA; the disease is breast cancer.